Entera Bio (ENTX) Operating Margin Growth (3y) (2022 - 2025)
Entera Bio (ENTX) Operating Margin Growth (3y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.50 Bn | 131.65 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.10 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 65.59 Bn | 60.41 Bn | 1.37 Bn | -537.00 |
| 4 | Moderna | 56.75 Bn | 51.62 Bn | 52.00 Mn | -1,934.00 |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 7,261.00 |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn | 9,003.00 |
| 7 | BioNTech SE | 27.80 Bn | 9.41 Bn | 668.28 Mn | -11,254.00 |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 30,461.00 |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | -2,649.00 |
| 10 | Entera Bio | 167.90 Mn | 156.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -46,268.00 |
| Dec 31, 2024 | -37,242.00 |
| Sep 30, 2024 | -489,286.00 |
| Jun 30, 2024 | -150,185.00 |
| Jun 30, 2022 | -464,220.00 |